
51 - 200 employés
🧬 Biotechnologie
🏥 Santé
💊 Pharmaceutique
Biotechnology • Healthcare • Pharmaceuticals
MeiraGTx est une société de médecine génétique intégrée verticalement, au stade clinique, qui se consacre au développement de thérapies géniques pour différentes pathologies, notamment les maladies rares et neurodégénératives. L’entreprise dispose de solides capacités en matière de conception et d’optimisation de vecteurs viraux, et exploite deux sites de production de vecteurs viraux conformes aux BPF (GMP), ainsi que son propre centre de contrôle qualité. MeiraGTx s’appuie sur des technologies innovantes, telles qu’une plateforme de régulation génique fondée sur les riboswitches, afin de contrôler précisément l’expression des gènes. Son objectif est d’améliorer l’administration de peptides métaboliques et d’étendre les applications de la médecine génétique au-delà des pathologies oculaires pour répondre à d’importants besoins médicaux non couverts dans diverses aires thérapeutiques.
🕒 il y a 3 jours
🇺🇸 États-Unis – Télétravail
⏰ Temps Plein
🟠 Senior
👔 Directeur
🦅 Parrain de Visa H1B
👻 Score fantôme 12%
🗣️🇺🇸🇬🇧 Anglais requis
D'où vient cette offre
Publiée sur la page carrières de MeiraGTx, pas via un site d'emploi
Repérée par Remote Rocketship il y a 3 jours
Toujours ouverte sur le site de MeiraGTx. Vérifiée il y a 1 heure.

51 - 200 employés
🧬 Biotechnologie
🏥 Santé
💊 Pharmaceutique
Biotechnology • Healthcare • Pharmaceuticals
MeiraGTx est une société de médecine génétique intégrée verticalement, au stade clinique, qui se consacre au développement de thérapies géniques pour différentes pathologies, notamment les maladies rares et neurodégénératives. L’entreprise dispose de solides capacités en matière de conception et d’optimisation de vecteurs viraux, et exploite deux sites de production de vecteurs viraux conformes aux BPF (GMP), ainsi que son propre centre de contrôle qualité. MeiraGTx s’appuie sur des technologies innovantes, telles qu’une plateforme de régulation génique fondée sur les riboswitches, afin de contrôler précisément l’expression des gènes. Son objectif est d’améliorer l’administration de peptides métaboliques et d’étendre les applications de la médecine génétique au-delà des pathologies oculaires pour répondre à d’importants besoins médicaux non couverts dans diverses aires thérapeutiques.
• Provide technical and operational leadership for statistical programming across clinical studies and development programs • Ensure the quality, accuracy, timeliness, traceability, and regulatory readiness of programming deliverables • Lead delivery of SDTM and ADaM datasets, tables, listings, figures, define.xml, reviewer guides, integrated analyses, exploratory analyses, and responses to regulatory questions • Provide hands-on leadership in a growing biotechnology environment • Provide strategic oversight of CROs and contractors • Partner effectively with cross-functional teams • Develop scalable standards, automation, and fit-for-purpose processes • Lead clinical programming and regulatory submission activities • Support quality, compliance, and inspection readiness • Manage strategic planning and risk management • Oversee CROs and vendors • Influence cross-functional stakeholders and solve technical problems • Travel up to 10–15% based on business needs • Provide flexibility during database locks, major submission milestones, or urgent regulatory responses
• Bachelor’s or advanced degree in Statistics, Biostatistics, Mathematics, Computer Science, Data Science, Life Sciences, or a related quantitative discipline • At least 10 years of statistical programming experience in the pharmaceutical, biotechnology, or CRO industry • Demonstrated study or program leadership, BLA/NDA/MAA submission experience, vendor oversight, and functional or people leadership • Advanced SAS programming skills, including SAS/BASE, SAS Macro, SAS SQL, ODS, and programming for clinical data analysis and reporting • Advanced knowledge of CDISC standards, including SDTM, ADaM, controlled terminology, define.xml, and associated implementation guidance • Experience producing and overseeing programming deliverables for clinical study reports and regulatory submissions • Working knowledge of the clinical drug-development process, clinical trial methodology, statistical concepts, GCP, ICH guidance, and electronic submission expectations • Experience with data and submission validation tools such as Pinnacle 21 and resolving validation findings in a documented, risk-based manner • Ability to manage multiple priorities, anticipate risks, negotiate realistic timelines, and deliver high-quality work in a fast-paced environment • Excellent written and verbal communication skills, sound judgment, attention to detail, and ability to influence effectively in a cross-functional matrix • Hands-on experience with global regulatory submissions, including NDA, BLA, MAA, or equivalent submissions, integrated summaries, information requests, inspections, and post-submission analyses • Experience in rare disease, gene therapy, ophthalmology, or another complex clinical-development setting • Experience with R and relevant clinical-development ecosystems; familiarity with Python, XML, Git, or metadata-driven reporting is an advantage • Experience building or governing reusable programming infrastructure, macro libraries, automated QC frameworks, and reproducible reporting workflows • Experience authoring or implementing SOPs, work instructions, programming standards, and vendor governance processes • Familiarity with validated cloud or collaborative programming environments and responsible use of AI-assisted programming tools • Preferred US Eastern Standard Time zone availability
• Remote work arrangement • Travel up to 10–15% based on business needs • Flexibility during database locks, major submission milestones, or urgent regulatory responses
Postuler MaintenantAméliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.
🕒 il y a 3 jours
Senior Director leading Medtronic’s U.S. Medicare reimbursement strategy for medical technologies. Translating CMS policy into access, adoption, and business growth decisions.
🇺🇸 États-Unis – Télétravail
💵 $253 600 - $380 400 / an
⏰ Temps Plein
🟠 Senior
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 jours
Senior DMPK leader advancing Centessa’s CNS medicines through discovery, regulatory submissions, and clinical development. Leading PK, ADME, toxicokinetic, and cross-functional project activities.
🇺🇸 États-Unis – Télétravail
💵 $177 000 - $338 800 / an
💰 €6 500 000 Post-IPO Debt - Eli Lilly en 2024-02
⏰ Temps Plein
🟠 Senior
👔 Directeur
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 jours
Sr. Director leading Lumicera’s specialty pharmacy industry partnerships, payor strategy, and market access. Expanding medication access, negotiating strategic agreements, and driving sustainable growth.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 jours
Senior commercial leader expanding revenue for OMNY Health’s healthcare data and analytics platform. Driving life sciences sales, strategic accounts, and post-sale growth.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 jours
Government relations leader securing federal funding and shaping US battery policy for QuantumScape, which develops solid-state lithium-metal batteries. Managing agency, congressional, White House, consultant, and standards relationships.
🇺🇸 États-Unis – Télétravail
💵 $189 748 - $303 668 / an
💰 €446 000 000 Post-IPO Equity en 2021-08
⏰ Temps Plein
🟠 Senior
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis